The -2518 A/G MCP-1 Polymorphism as a Risk Factor of Inflammatory Bowel Disease
Languages of publication
Inflammatory bowel diseases (IBD) are disorders originated from immune disturbances.The aim of the study was to evaluate the association between the -2518 A/G MCP-1 polymorphism and the risk of IBD development.Material and methods. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Study group consisted of 197 subjects with IBD (120 with ulcerative colitis and 77 with Crohn's disease) as well as 210 healthy controls.Results. The presence of the -2518 G/G MCP-1 genotype in the investigated groups seems to be connected with higher risk of inflammatory bowel disease as well as Crohn's disease only (OR 2.26; 95% CI 1.44-3.54 and OR 2.08; 95% CI 1.21-3.46, respectively).Conclusions. Our data showed that the -2518 A/G MCP-1 polymorphism might be associated with the IBD occurrence and might be used as predictive factor of these diseases in a Polish population.
1 - 5 - 2012
4 - 7 - 2012
- Labbe K, Danialou G, Gvozdic D et al.: Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia. Crit Care 2010; 14: R187.[Crossref][WoS]
- Yadav A, Saini V, Arora S: MCP-1: chemoattractant with a role beyond immunity: a review. Clin Chim Acta 2010; 411: 1570-79.[WoS]
- Weber B, Saurer L, Mueller C: Intestinal macrophages: differentiation and involvement in intestinal immunopathologies. Semin Immunopathol 2009; 31: 171-84.[WoS]
- Grimm MC, Elsbury S K, Pavli P et al.: Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996; 59: 804-12.
- Motomura Y, Ghia JE, Wang H et al.: Enterochromaffin cell and 5-hydroxytryptamine responses to the same infectious agent differ in Th1 and Th2 dominant environments. Gut 2008; 57: 475-81.[WoS]
- Fenoglio C, Galimberti D, Lovati C et al.: MCP-1 in Alzheimer's disease patients: A-2518G polymorphism and serum levels. Neurobiol Aging 2004; 25: 1169-73.
- Reinecker HC, Loh E Y, Ringler DJ et al.: Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995; 108: 40-50.
- Herfarth H, Goke M, Hellerbrand C et al.: Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease. Int J Colorectal Dis 2003; 18: 401-05.
- Palmieri O, Latiano A, Salvatori E et al.: The -A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease. Am J Gastroenterol 2010; 105: 1586-94.
- Gorgi Y, Aleya WB, Khazen D et al.: Genetic polymorphisms of inflammatory molecules in Tunisian inflammatory bowel diseases. J Trans Med 2010; 8: Suppl 1.
Publication order reference